Records containing: Non-Small Cell Lung Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-02Phase Ib/II Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.
-
CLINICAL_TRIALS study record update · 2025-10-02ALCMI-011: Study of Plasma Next Generation Sequencing for Assessment, Characterization, Evaluation of Patients With ALK Resistance (SPACEWALK)
-
CLINICAL_TRIALS study record update · 2025-10-01Overcoming Instrumentation Challenges in Real-World Uniportal Video-Assisted Thoracoscopic Surgery: A Prospective, Randomized, Controlled Trial Evaluating the SurgeoFlex Grasp Versus the Traditional Endograsper for Systemic Lymph Node Dissection in Patients With Early-Stage Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-09-26An Open-label, Multicenter, Single-arm Phase 2 Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-09-25EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-19An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects With Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-09-18A Randomized Phase II Trial to Assess the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
-
CLINICAL_TRIALS study record update · 2025-09-18First in Human Phase 1 Study of AOH1996 in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-09-16Efficacy and Safety of Primary Tumor Resection Combined With Osimertinib in Patients With Advanced EGFR-mutant Non-small Cell Lung Cancer: A Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2025-09-15A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-09-10An Open-label Phase II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of ABSK043 in Combination With Glecirasib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring a KRAS G12C Mutation
-
CLINICAL_TRIALS study record update · 2025-09-08A Single Arm, Multi-center, Phase II Study of AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC) Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment
-
CLINICAL_TRIALS study record update · 2025-09-05A Study to Evaluate the Safety and Immune Activity of PeptiCRAd-1 in Combination With Pembrolizumab in Patients With Injectable Solid Tumors in Indications Known to Express NY-ESO-1 and MAGE-A3
-
CLINICAL_TRIALS study record update · 2025-08-27A Phase II Study of Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Who Have Had Prior Treatment With a PD-1 Inhibitor
-
CLINICAL_TRIALS study record update · 2025-08-22Metabolic Signatures Predictive of Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-08-19A Phase 1, Open-Label, Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Aumolertinib in European Participants With Locally Advanced or Metastatic, EGFR-mutated Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-08-17A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-08-12Construction of a Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy
-
CLINICAL_TRIALS study record update · 2025-08-12A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 In Completely Resected Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-08-11A Phase II/III, Open-Label, Randomised Study to Assess the Safety and Efficacy of D-0316 Versus Icotinib as First Line Treatment in Patients With EGFR Sensitising Mutation, Locally Advanced or Metastatic NSCLC
-
CLINICAL_TRIALS study record update · 2025-08-08The Role of Artificial Intelligence in Predicting Stage and Survival in Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-08-07Prospective, Randomized Controlled Clinical Trial of Glutathione Combined With PD-1 Antibody and Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-08-07An Open-label Phase Ib Study on the Safety, Tolerability, and Efficacy of BT02 in Treating Patients With Advanced Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-08-06Comparing Radiomics, Deep Learning, and Fusion Models for Predicting Occult Pleural Dissemination in Patients With Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-08-04Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)